Why the study?
Does lower remnant cholesterol reduce recurrent MACE in individuals with a diagnosis of myocardial infarction or ischaemic stroke?
Population
Individuals with a diagnosis of myocardial infarction or ischaemic stroke
Authors
Loading...
Hypothesis-generating for remnant cholesterol lowering in secondary prevention; randomized trials needed to confirm effects on recurrent MACE.
Does lower remnant cholesterol reduce recurrent MACE in individuals with a diagnosis of myocardial infarction or ischaemic stroke?
Lowering remnant cholesterol may significantly reduce recurrent MACE in secondary prevention for patients with prior MI or ischemic stroke.
Langsted et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: